Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review

V Narayan, EW Thompson, B Demissei, JE Ho… - Journal of the American …, 2020 - jacc.org
Cardiovascular disease (CVD) and cancer are leading causes of morbidity and mortality
worldwide. Although conventionally managed as separate disease processes, recent …

Shared risk factors in cardiovascular disease and cancer

RJ Koene, AE Prizment, A Blaes, SH Konety - Circulation, 2016 - Am Heart Assoc
Cardiovascular disease (CVD) and cancer are the 2 leading causes of death worldwide.
Although commonly thought of as 2 separate disease entities, CVD and cancer possess …

Cardiovascular disease and cancer: shared risk factors and mechanisms

NS Wilcox, U Amit, JB Reibel, E Berlin… - Nature Reviews …, 2024 - nature.com
Cardiovascular disease (CVD) and cancer are among the leading causes of morbidity and
mortality globally, and these conditions are increasingly recognized to be fundamentally …

Cardiovascular disease and cancer: is there increasing overlap?

L Vincent, D Leedy, SC Masri, RK Cheng - Current oncology reports, 2019 - Springer
Abstract Purpose of Review Cancer and cardiovascular disease are the leading causes of
mortality in the USA. In this review, we highlight these shared disease pathways and provide …

[HTML][HTML] Cardio-oncology: a myriad of relationships between cardiovascular disease and cancer

Y Wang, Y Wang, X Han, J Sun, C Li… - Frontiers in …, 2022 - frontiersin.org
Cardiovascular disease (CVD) and cancer are the leading causes of death worldwide. With
an increasing number of the elderly population, and early cancer screening and treatment …

Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology

P Libby, S Kobold - Cardiovascular research, 2019 - academic.oup.com
Inflammation participates in the pathogenesis of both cancer and cardiovascular disease.
This review examines the mechanistic commonalities between these two scourges of …

Heart disease and cancer: are the two killers colluding?

RN Kitsis, JA Riquelme, S Lavandero - Circulation, 2018 - Am Heart Assoc
Noncommunicable diseases kill 40 million people each year, accounting for 70% of all
deaths globally. In this context, 17.7 million people die annually as a consequence of …

Future perspectives of cardiovascular biomarker utilization in cancer survivors: a scientific statement from the American Heart Association

VG Zaha, SS Hayek, KM Alexander, TM Beckie… - Circulation, 2021 - Am Heart Assoc
Improving cancer survival represents the most significant effect of precision medicine and
personalized molecular and immunologic therapeutics. Cardiovascular health becomes …

Cardio-oncology: understanding the intersections between cardiac metabolism and cancer biology

A Karlstaedt, M Barrett, R Hu, ST Gammons… - Basic to Translational …, 2021 - jacc.org
An important priority in the cardiovascular care of oncology patients is to reduce morbidity
and mortality, and improve the quality of life in cancer survivors through cross-disciplinary …

[HTML][HTML] Atherosclerosis, diabetes mellitus, and cancer: common epidemiology, shared mechanisms, and future management

V Katsi, I Papakonstantinou, K Tsioufis - International Journal of …, 2023 - mdpi.com
The involvement of cardiovascular disease in cancer onset and development represents a
contemporary interest in basic science. It has been recognized, from the most recent …